DK2812435T3 - Transskriptionsenheder og anvendelse heraf i ekspressionsvektorer - Google Patents

Transskriptionsenheder og anvendelse heraf i ekspressionsvektorer Download PDF

Info

Publication number
DK2812435T3
DK2812435T3 DK13709486.8T DK13709486T DK2812435T3 DK 2812435 T3 DK2812435 T3 DK 2812435T3 DK 13709486 T DK13709486 T DK 13709486T DK 2812435 T3 DK2812435 T3 DK 2812435T3
Authority
DK
Denmark
Prior art keywords
trances
express vectors
critical units
critical
units
Prior art date
Application number
DK13709486.8T
Other languages
English (en)
Inventor
Alexandre Fontayne
François Coutard
Original Assignee
Lab Francais Du Fractionnement
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lab Francais Du Fractionnement filed Critical Lab Francais Du Fractionnement
Application granted granted Critical
Publication of DK2812435T3 publication Critical patent/DK2812435T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2887—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD20
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/34—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood group antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/007—Vector systems having a special element relevant for transcription cell cycle specific enhancer/promoter combination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/15—Vector systems having a special element relevant for transcription chimeric enhancer/promoter combination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/42—Vector systems having a special element relevant for transcription being an intron or intervening sequence for splicing and/or stability of RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/60—Vector systems having a special element relevant for transcription from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK13709486.8T 2012-02-08 2013-02-08 Transskriptionsenheder og anvendelse heraf i ekspressionsvektorer DK2812435T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1251185A FR2986536A1 (fr) 2012-02-08 2012-02-08 Unites de transcription et leur utilisation dans des vecteurs d'expression (cho)
PCT/FR2013/050267 WO2013117871A2 (fr) 2012-02-08 2013-02-08 Unités de transcription et leur utilisation dans des vecteurs d'expression

Publications (1)

Publication Number Publication Date
DK2812435T3 true DK2812435T3 (da) 2019-07-15

Family

ID=47884386

Family Applications (1)

Application Number Title Priority Date Filing Date
DK13709486.8T DK2812435T3 (da) 2012-02-08 2013-02-08 Transskriptionsenheder og anvendelse heraf i ekspressionsvektorer

Country Status (6)

Country Link
US (1) US9512230B2 (da)
EP (1) EP2812435B1 (da)
DK (1) DK2812435T3 (da)
ES (1) ES2731954T3 (da)
FR (1) FR2986536A1 (da)
WO (1) WO2013117871A2 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3034420A1 (fr) 2015-03-31 2016-10-07 Lab Francais Du Fractionnement Anticorps monoclonaux anti-cd303

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5024939A (en) * 1987-07-09 1991-06-18 Genentech, Inc. Transient expression system for producing recombinant protein
EP0894853A1 (en) * 1997-07-24 1999-02-03 Gesellschaft für Biotechnologische Forschung mbH (GBF) Transcriptional silencer protein NRF, nucleic acid molecules encoding it and their use
WO2000055378A1 (en) * 1999-03-16 2000-09-21 Dana-Farber Cancer Institute, Inc. Lentiviral vector system for high quantity screening
US20030224477A1 (en) * 2002-05-31 2003-12-04 Heartlein Michael W. Optimized promoter constructs
US20040132679A1 (en) * 2002-09-03 2004-07-08 Baylor College Of Medicine Induction of pancreatic islet formation
AU2004295590B2 (en) * 2003-12-03 2010-04-29 Chugai Seiyaku Kabushiki Kaisha Expression systems using mammalian beta-actin promoter
CN1934260B (zh) * 2004-01-22 2013-03-13 株式会社载体研究所 利用含有巨细胞病毒增强子和鸡β-肌动蛋白启动子的杂合启动子制造负链RNA病毒载体的方法
JP2007537755A (ja) * 2004-05-18 2007-12-27 イントレクソン コーポレイション Ｄｎａクローニングベクタープラスミドのダイナミックなベクター構築のための方法
EP1934358A2 (en) * 2005-10-13 2008-06-25 Genentech, Inc. Transgenic rosa26-luciferase mice for bioluminescent imaging
CN101522899B (zh) * 2006-10-10 2012-07-25 百疗医株式会社 安全性改善的表达载体
US20090271884A1 (en) * 2008-03-07 2009-10-29 Regeneron Pharmaceuticals, Inc. ES Cell-Derived Mice From Diploid Host Embryo Injection
CA2781332C (en) * 2009-11-19 2018-09-04 National University Corporation Okayama University System for increasing gene expression and vector comprising the system

Also Published As

Publication number Publication date
WO2013117871A2 (fr) 2013-08-15
FR2986536A1 (fr) 2013-08-09
EP2812435A2 (fr) 2014-12-17
WO2013117871A3 (fr) 2014-01-09
US9512230B2 (en) 2016-12-06
ES2731954T3 (es) 2019-11-19
US20150072368A1 (en) 2015-03-12
EP2812435B1 (fr) 2019-04-03

Similar Documents

Publication Publication Date Title
IL262600B (en) Vectors and their medical uses
DK2920197T3 (da) Prolinlåste sammenhæftede peptider og anvendelser deraf
DK2920313T3 (da) Rekombinante adenovira og anvendelse deraf
DK3346008T3 (da) Rekombinante mikroorganismer og anvendelser deraf
DK2872419T3 (da) Fordelingsbeholder og tilsvarende fremgangsmåde
DK2850202T3 (da) Fremgangsmåder og grupper
DK2855736T3 (da) Elektrolysator og energisystem
EP2870170A4 (en) NOVEL PEPTIDES AND THEIR USE
DK2844282T3 (da) Prostata-associerede antigener og vaccine-baserede immunterapiregimener
DK2868102T3 (da) Tiles og wavefront front parallel processering
DK2903600T3 (da) Virusholdig formulering og anvendelse deraf
DK2812356T3 (da) CDIM-bindende proteiner og anvendelser deraf
DK2552434T3 (da) Peptider og anvendelse deraf
DK3326642T3 (da) Langtidsvirkende koagulationsfaktorer og brugen deraf
SG11201500111VA (en) Peptides and uses thereof
DK3453723T3 (da) Anti-ASIC1-antistoffer og anvendelser deraf
DK3567099T3 (da) Nyrecellepopulationer og anvendelser deraf
SG11201501646PA (en) Peptides and their uses
DK2883954T3 (da) Peptidbibliotek og anvendelse deraf
DK2704744T3 (da) Komplementfaktor-b-analoger og anvendelser deraf
DK2935035T3 (da) Beholder og fastgørelser deraf
HK1208735A1 (en) Electrochromic cells and their use
DK2943460T3 (da) 6-chlor-3-(phenyl-d5)-inden-1-on og anvendelse deraf
DK2877494T3 (da) PTPRS og proteoglycaner i autoimmun sygdom
EP2825548A4 (en) MODIFIED KISSPEPTIN PEPTIDES AND USES THEREOF